James R Faulkner
James R Faulkner
NOAA National Marine Fisheries Service, previously at Fred Hutchinson Cancer Research Center
Verified email at noaa.gov
Title
Cited by
Cited by
Year
Surgical factors influence bladder cancer outcomes: a cooperative group report
HW Herr, JR Faulkner, HB Grossman, RB Natale, R deVere White, ...
Journal of clinical oncology 22 (14), 2781-2789, 2004
6102004
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest …
M Hussain, CM Tangen, C Higano, PF Schelhammer, J Faulkner, ...
Journal of clinical oncology 24 (24), 3984-3990, 2006
4632006
Simple life-history traits explain key effective population size ratios across diverse taxa
RS Waples, G Luikart, JR Faulkner, DA Tallmon
Proceedings of the Royal Society B: Biological Sciences 280 (1768), 20131339, 2013
1782013
Ten-year survival in patients with metastatic prostate cancer
CM Tangen, JR Faulkner, ED Crawford, IM Thompson, D Hirano, ...
Clinical prostate cancer 2 (1), 41-45, 2003
932003
Survival estimates for the passage of spring-migrating juvenile salmonids through Snake and Columbia River dams and reservoirs, 2006
JR Faulkner, SG Smith, WD Muir, DM Marsh, JG Williams
Report of the National Marine Fisheries Service to the Bonneville Power …, 2007
652007
Phase II trial of carboplatin and paclitaxel in cisplatin‐pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study
UN Vaishampayan, JR Faulkner, EJ Small, BG Redman, WL Keiser, ...
Cancer 104 (8), 1627-1632, 2005
612005
Pathologic evaluation of radical cystectomy specimens: a cooperative group report
HW Herr, JR Faulkner, HB Grossman, ED Crawford
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
60*2004
A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109
PJ Van Veldhuizen, JR Faulkner, PN Lara, PH Gumerlock, JW Goodwin, ...
Cancer chemotherapy and pharmacology 56 (1), 39-45, 2005
412005
Evaluation of ZD1839 for advanced transitional cell carcinoma (TCC) of the urothelium: a Southwest Oncology Group Trial
D Petrylak, JR Faulkner, PJ Van Veldhuizen, M Mansukhani, ED Crawford
Proc Am Soc Clin Oncol 22, 403, 2003
402003
Comprehensive passage (COMPASS) model: a model of downstream migration and survival of juvenile salmonids through a hydropower system
RW Zabel, J Faulkner, SG Smith, JJ Anderson, C Van Holmes, N Beer, ...
Hydrobiologia 609 (1), 289-300, 2008
352008
Locally adaptive smoothing with Markov random fields and shrinkage priors
JR Faulkner, VN Minin
Bayesian analysis 13 (1), 225, 2018
332018
Southwest Oncology Group Trial 9346 (INT-0162). Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new …
M Hussain, CM Tangen, C Higano, PF Schelhammer, J Faulkner, ...
J Clin Oncol 24 (24), 3984, 2006
292006
Modelling evolutionary processes in small populations: not as ideal as you think
RS Waples, JR Faulkner
Molecular Ecology 18 (9), 1834-1847, 2009
212009
Epothilone B (Epo-B) analogue BMS-247550 (NSC# 710428) administered every 21 days in patients (pts) with hormone refractory prostate cancer (HRPC). A Southwest Oncology Group …
M Hussain, J Faulkner, U Vaishampayan, P Lara, D Petrylak, D Colevas, ...
Journal of Clinical Oncology 22 (14_suppl), 4510-4510, 2004
192004
Human-mediated evolution in a threatened species? Juvenile life-history changes in Snake River salmon
RS Waples, A Elz, BD Arnsberg, JR Faulkner, JJ Hard, ...
Evolutionary Applications, 2017
172017
Quantifying cumulative entrainment effects for Chinook salmon in a heavily irrigated watershed
AW Walters, DM Holzer, JR Faulkner, CD Warren, PD Murphy, ...
Transactions of the American Fisheries Society 141 (5), 1180-1190, 2012
172012
Conservation planning for freshwater–marine carryover effects on Chinook salmon survival
JL Gosselin, RW Zabel, JJ Anderson, JR Faulkner, AM Baptista, ...
Ecology and evolution 8 (1), 319-332, 2018
162018
Horseshoe‐based Bayesian nonparametric estimation of effective population size trajectories
JR Faulkner, AF Magee, B Shapiro, VN Minin
Biometrics 76 (3), 677-690, 2020
13*2020
Rejoinder for discussion on “Horseshoe‐based Bayesian nonparametric estimation of effective population size trajectories”
JR Faulkner, AF Magee, B Shapiro, VN Minin
Biometrics 76 (3), 695-699, 2020
11*2020
Treatment options for muscle‐invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine …
CS Higano, CM Tangen, WA Sakr, J Faulkner, SE Rivkin, FJ Meyers, ...
Cancer 112 (10), 2181-2187, 2008
112008
The system can't perform the operation now. Try again later.
Articles 1–20